The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis
Authors
Keywords
Bone density, Diabetes mellitus, Meta-analysis, Pioglitazone, Rosiglitazone, Systematic review, Thiazolidinediones
Journal
DIABETOLOGIA
Volume 58, Issue 10, Pages 2238-2246
Publisher
Springer Nature
Online
2015-06-24
DOI
10.1007/s00125-015-3660-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Skeletal health in adults with HIV infection
- (2015) Mark J Bolland et al. Lancet Diabetes & Endocrinology
- Risk of fracture with thiazolidinediones: An updated meta-analysis of randomized clinical trials
- (2014) Zhong-Ning Zhu et al. BONE
- Intensive Glycemic Control and Thiazolidinedione Use: Effects on Cortical and Trabecular Bone at the Radius and Tibia
- (2013) Ann V. Schwartz et al. CALCIFIED TISSUE INTERNATIONAL
- Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial
- (2013) G. A. Bray et al. DIABETES OBESITY & METABOLISM
- The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial
- (2013) Andrew Grey et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of Pioglitazone on Bone in Postmenopausal Women With Impaired Fasting Glucose or Impaired Glucose Tolerance: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus
- (2013) John P. Bilezikian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus
- (2012) A H van Lierop et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Bone Effects of Rosiglitazone in HIV-Infected Patients With Lipoatrophy
- (2012) Allison C. Ross et al. HIV CLINICAL TRIALS
- Effect of Rosiglitazone on Bone Quality in a Rat Model of Insulin Resistance and Osteoporosis
- (2011) L. D. Sardone et al. DIABETES
- A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 d
- (2011) J. L. C. Borges et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy
- (2011) Kim Henriksen et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Rosiglitazone Decreases Bone Mass and Bone Marrow Fat
- (2011) Torben Harsløf et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
- (2011) Astrid K Stunes et al. BMC Endocrine Disorders
- A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206
- (2010) Marisa Tungsiripat et al. AIDS
- The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial
- (2010) Ugis Gruntmanis et al. CALCIFIED TISSUE INTERNATIONAL
- Osteoblast physiology in normal and pathological conditions
- (2010) Anna Neve et al. CELL AND TISSUE RESEARCH
- ORIGINAL ARTICLE: Effects of rosiglitazone on bone mineral density and remodelling parameters in Postmenopausal diabetic women: a 2-year follow-up study
- (2010) Zehra Berberoglu et al. CLINICAL ENDOCRINOLOGY
- Thiazolidinediones induce osteocyte apoptosis and increase sclerostin expression
- (2010) G. Mabilleau et al. DIABETIC MEDICINE
- Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus
- (2010) I. Kanazawa et al. OSTEOPOROSIS INTERNATIONAL
- Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes
- (2009) John Dormandy et al. DRUG SAFETY
- The Effect of Rosiglitazone on Insulin Sensitivity, Beta Cell Function, Bone Mineral Density, and Body Composition in HIV-positive Patients on Highly-active Antiretroviral Therapy (HAART)
- (2009) K. Schindler et al. HORMONE AND METABOLIC RESEARCH
- A Cohort Study of Thiazolidinediones and Fractures in Older Adults with Diabetes
- (2009) Daniel H. Solomon et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
- (2009) Bernard Zinman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study
- (2009) Ian J. Douglas et al. PLOS MEDICINE
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
- (2008) Y. K. Loke et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Imputation methods for missing outcome data in meta-analysis of clinical trials
- (2008) Julian PT Higgins et al. Clinical Trials
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Association of Pioglitazone Treatment with Decreased Bone Mineral Density in Obese Premenopausal Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial
- (2008) Dorte Glintborg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Risk Factors for Longitudinal Bone Loss in Elderly Men and Women: The Framingham Osteoporosis Study
- (2006) Marian T. Hannan et al. JOURNAL OF BONE AND MINERAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started